Andaleeb Sajid

Dr. Andaleeb Sajid

Section of Infectious Diseases, Yale School of Medicine, Yale university, New Haven 06519, Connecticut USA
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2023 in Nature Reviews Cancer
Verified
Journal Article
Closed access
PDF file
Andaleeb SajidAndaleeb Sajid
Andaleeb Sajid
HRHadiar Rahman
Hadiar Rahman
SASuresh V. Ambudkar
Suresh V. Ambudkar

18 December 2019 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Closed access
SUSunita
Sunita
Andaleeb SajidAndaleeb Sajid
Andaleeb Sajid
YSYogendra Singh
Yogendra Singh
Pratyoosh ShuklaPratyoosh Shukla
Pratyoosh Shukla
SVSunita Verma
Sunita Verma
Vaccines play an essential role in controlling the rates of fatality and morbidity. Vaccines not only arrest the beginning of different diseases but also assign a gateway for its elimination and reduce toxicity. This review gives an overview of the possible uses of computational tools for vaccine design. Moreover, we have described the initiatives of utilizing the diverse computational resources by exploring the immunological databases for developing epitope-based vaccines, peptide-based drugs, and other resources of immunotherapeutics. Finally, the applications of multi-graft and multivalent scaffolding, codon optimization and antibodyomics tools in identifying and designing in silico vaccine candidates are described.

17 November 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
Andaleeb SajidAndaleeb Sajid
Andaleeb Sajid
JMJaqueline Matias
Jaqueline Matias
Gunjan AroraGunjan Arora
Gunjan Arora
CKCheyne Kurokawa
Cheyne Kurokawa
KDKathleen DePonte
Kathleen DePonte
EFErol Fikrig
Erol Fikrig
An Ixodes scapularis saliva mRNA vaccine induces tick resistance and prevents Borrelia burgdorferi infection in guinea pigs.

1 November 2018 in Cell
Verified
Journal Article
Open access
Yin Yao DongYin Yao Dong
Yin Yao Dong
HWHua Wang
Hua Wang
APAshley C.W. Pike
Ashley C.W. Pike
SCStephen A. Cochrane
Stephen A. Cochrane
SHSadra Hamedzadeh
Sadra Hamedzadeh
ECElisabeth P. Carpenter
Elisabeth P. Carpenter
Protein N-glycosylation is a widespread post-translational modification. The first committed step in this process is catalysed by dolichyl-phosphate N-acetylglucosamine-phosphotransferase DPAGT1 (GPT/E.C. 2.7.8.15). Missense DPAGT1 variants cause congenital myasthenic syndrome and disorders of glycosylation. In addition, naturally-occurring bactericidal nucleoside analogues such as tunicamycin are toxic to eukaryotes due to DPAGT1 inhibition, preventing their clinical use. Our structures of DPAGT1 with the substrate UDP-GlcNAc and tunicamycin reveal substrate binding modes, suggest a mechanism of catalysis, provide an understanding of how mutations modulate activity (thus causing disease) and allow design of non-toxic "lipid-altered" tunicamycins. The structure-tuned activity of these analogues against several bacterial targets allowed the design of potent antibiotics for Mycobacterium tuberculosis, enabling treatment in vitro, in cellulo and in vivo, providing a promising new class of antimicrobial drug.

1 October 2011 in Journal of Bacteriology
Verified
Journal Article
Closed access
PDF file
Andaleeb SajidAndaleeb Sajid
Andaleeb Sajid
GAGunjan Arora
Gunjan Arora
MGMeetu Gupta
Meetu Gupta
ASAnshika Singhal
Anshika Singhal
KCKausik Chakraborty
Kausik Chakraborty
YSYogendra Singh
Yogendra Singh
During protein synthesis, translation elongation factor Tu (Ef-Tu) is responsible for the selection and binding of the cognate aminoacyl-tRNA to the acceptor site on the ribosome. The activity of Ef-Tu is dependent on its interaction with GTP. Posttranslational modifications, such as phosphorylation, are known to regulate the activity of Ef-Tu in several prokaryotes. Although a study of the Mycobacterium tuberculosis phosphoproteome showed Ef-Tu to be phosphorylated, the role of phosphorylation in the regulation of Ef-Tu has not been studied. In this report, we show that phosphorylation of M. tuberculosis Ef-Tu ( Mtb Ef-Tu) by PknB reduced its interaction with GTP, suggesting a concomitant reduction in the level of protein synthesis. Overexpression of PknB in Mycobacterium smegmatis indeed reduced the level of protein synthesis. Mtb Ef-Tu was found to be phosphorylated by PknB on multiple sites, including Thr 118 , which is required for optimal activity of the protein. We found that kirromycin, an Ef-Tu-specific antibiotic, had a significant effect on the nucleotide binding of unphosphorylated Mtb Ef-Tu but not on the phosphorylated protein. Our results show that the modulation of the Mtb Ef-Tu–GTP interaction by phosphorylation can have an impact on cellular protein synthesis and growth. These results also suggest that phosphorylation can change the sensitivity of the protein to the specific inhibitors. Thus, the efficacy of an inhibitor can also depend on the posttranslational modification(s) of the target and should be considered during the development of the molecule.

15 October 2015 in Annual Review of Microbiology
Verified
Journal Article
Closed access
Andaleeb SajidAndaleeb Sajid
Andaleeb Sajid
GAGunjan Arora
Gunjan Arora
ASAnshika Singhal
Anshika Singhal
VKVipin C. Kalia
Vipin C. Kalia
YSYogendra Singh
Yogendra Singh
The role of protein phosphatases in pathogenic bacteria has been studied extensively over the last two decades. Ser/Thr and Tyr phosphatases are associated with growth and virulence of many bacteria. These phosphatases control kinase-mediated functions and return the proteins to their unmodified state. Biochemical, structural, and functional studies, in addition to extensive genetic characterization, have highlighted the importance of phosphatases in bacteria. However, questions remain regarding the mechanisms driving localization of secretory phosphatases to cellular compartments, identification of receptor phosphatase sensory signals, and a possible role of cofactors and ligands in their functions. This review focuses on the role of Ser/Thr- and Tyr-specific phosphatases present in pathogenic bacteria, with an emphasis on the regulation of basic cellular processes and virulence. Furthermore, we highlight their clinical importance and analyze the development of drugs targeting protein phosphatases.